# [GNA13]

## Mutation tier

|Entity|Tier|
|------|----|
|BL    |1   |
|DLBCL |1   |
|FL    |1   |

## Mutation incidence

|Entity|study                |frequency (%)|
|------|---------------------|-------------|
|BL    |GAMBL genomes+capture|21.02        |
|BL    |Thomas cohort        |21.60        |
|BL    |Panea cohort         |20.80        |
|DLBCL |GAMBL genomes        |11.70        |
|DLBCL |Schmitz cohort       | 8.50        |
|DLBCL |Reddy cohort         |11.90        |
|DLBCL |Chapuy cohort        |10.30        |
|FL    |GAMBL genomes        |10.16        |

## Mutation pattern

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|------|----|---------------------|----------------|----------------|
|BL    |No  |Yes                  |51.517          |966.741         |
|DLBCL |No  |Yes                  |38.484          |284.077         |
|FL    |No  |Yes                  |48.688          |215.216         |


> [!NOTE]
> First described in BL in 2012 by [Love C](https://pubmed.ncbi.nlm.nih.gov/23143597). First described in DLBCL in 2011 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/21796119). First described in FL in 2011 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/21796119)